Canadian Respiratory Journal / 2017 / Article / Tab 3

Research Article

Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients

Table 3

Performance of GM detection for diagnosis of IPA in BALF.

Cutoff valueSensitivity%Specificity%PPV%NPV%

BALF GM ≥ 0.5100.0%64.3%16.4%100.0%
BALF GM ≥ 0.76100.0%76.2%22.7%100.0%
BALF GM ≥ 0.890.0%78.3%22.5%99.1%
BALF GM ≥ 1.070.0%82.5%21.9%97.5%
BALF GM ≥ 1.560.0%86.0%23.1%96.8%
BALF GM ≥ 2.050.0%88.8%23.8%96.2%

GM, galactomannan; IPA, invasive pulmonary aspergillosis; BALF, bronchoalveolar lavage fluid; PPV, positive predictive value; NPV, negative predictive value.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.